FDA
approval
· 2020-09-30
FDA Approved: ELETRIPTAN HYDROBROMIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
The FDA approved a supplemental application for Eletriptan hydrobromide from Mylan Pharmaceuticals Inc., authorizing a generic version for the acute treatment o…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)